TomoTherapy scores Italy order

TriMed Staff | | Health Imaging | Practice Management
Azienda Ospedaliero - Universitaria di Modena in Modena, Italy, has selected TomoTherapy’s Hi-Art treatment system to deliver radiation therapy to cancer patients in the region.

Stefano Cencetti, MD, executive director of Azienda, said the system will provide radiation therapy for cancer cases involving the brain, head and neck, lung, liver and prostate.

“Our center is also working on Partial Breast Irradiation Trials and we will conduct research involving TomoTherapy for total body irradiation and total lymph node irradiation,” he added.

TriMed Staff

Related Content

MRI accident has prompted the company that installed the scanner to issue a safety warning
Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.